Monopar Therapeutics Inc. Intrinsic Value

MNPR

Monopar Therapeutics fair value

None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for Monopar Therapeutics today, so there is nothing to project yet.

Peers

Pharmaceutical Preparations · Pick stocks to compare with MNPR

CompareIntrinsic value

DERMJourney Medical Corp

$4.73+1.94%25

SPROSpero Therapeutics Inc.

$1.07+2.88%63

ABUSArbutus Biopharma Corporation

$4.06+4.64%60

LGVNLongeveron Inc.

$1.78+0.00%10

INOInovio Pharmaceuticals, Inc.

$1.62-2.41%10

SPRBSpruce Biosciences Inc.

$46.61+8.88%10

ALTAltimmune, Inc.

$2.12+3.92%10

AZTRAzitra Inc.

$0.82-7.69%19

Held by ETFs

MNPR is in 10 US ETFs. The largest of them, with MNPR's weight in each:

Spot a number that looks wrong? Check it in MNPR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MNPR

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.